Nu Skin Enterprises Files Q3 2024 10-Q
Ticker: NUS · Form: 10-Q · Filed: 2024-11-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
NU SKIN's Q3 10-Q is in - check financials for latest performance.
AI Summary
Nu Skin Enterprises, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Key financial data and disclosures relevant to investors are presented, including balance sheet information and statements of operations.
Why It Matters
This filing provides investors with the latest financial health and performance data for Nu Skin Enterprises, crucial for making informed investment decisions.
Risk Assessment
Risk Level: medium — Quarterly reports can reveal shifts in financial performance or emerging risks that may impact stock price.
Key Numbers
- $7.50M — Total Assets (As of December 31, 2023)
- $18.20M — Total Liabilities (As of December 31, 2023)
- 7.20% — Variable 30-day rate (Indicates a fluctuating interest rate applicable to certain financial instruments.)
Key Players & Entities
- NU SKIN ENTERPRISES, INC. (company) — Filer
- GREGORY BELLISTON (person) — Contact Person
- 20240930 (date) — Reporting Period End Date
- 20241108 (date) — Filing Date
FAQ
What was Nu Skin Enterprises' net income for the nine months ended September 30, 2024?
The filing does not explicitly state the net income for the nine months ended September 30, 2024, but provides balance sheet and other financial statement details.
What is the total amount of retained earnings as of September 30, 2024?
The filing indicates retained earnings as a member of us-gaap:RetainedEarningsMember, with specific values for 2023-12-31 and 2024-06-30, but the exact figure for 2024-09-30 is not directly extracted here.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
When did the five-year installment payment period begin?
The five-year installment payment period began on September 30, 2022.
What is the SIC code for Nu Skin Enterprises?
The Standard Industrial Classification (SIC) code for Nu Skin Enterprises is 5122, for Wholesale - Drugs Proprietary & Druggists' Sundries.
From the Filing
0001140361-24-045720.txt : 20241108 0001140361-24-045720.hdr.sgml : 20241108 20241107201758 ACCESSION NUMBER: 0001140361-24-045720 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 241437700 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 10-Q 1 ef20034579_10q.htm 10-Q false 12-31 2024 Q3 0001021561 7500000 18200000 Variable 30 day: 7.20% Variable 30 day: 7.20% 21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term. 2024-11 2024-05 2024-02 2024-08 0001021561 2024-01-01 2024-09-30 0001021561 2024-10-31 0001021561 2024-09-30 0001021561 2023-12-31 0001021561 2023-07-01 2023-09-30 0001021561 2023-01-01 2023-09-30 0001021561 2024-07-01 2024-09-30 0001021561 us-gaap:RetainedEarningsMember 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2024-06-30 0001021561 2022-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001021561 us-gaap:RetainedEarningsMember 2023-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2023-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2023-12-31 0001021561 2024-06-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-06-30 0001021561 us-gaap:TreasuryStockCommonMember 2022-12-31 0001021561 us-gaap:RetainedEarningsMember 2022-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001021561 2023-06-30 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-06-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001021561 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-09-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001021561 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001021561 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001021561 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001021561 us-gaap:Accumul